|
Programme Highlights
§ Addressing the challenges of anaemia and thrombocytopenia in myelofibrosis
§ Diagnosis and treatment of AL amyloidosis
§ Germline predisposition to haematological malignancies
§ Latest updates on management of lymphoma, acute leukemia, paroxysmal nocturnal haemoglobinuria and multiple myeloma
§ CAR-T cell therapy and bispecific antibodies in the treatment of haematological malignancies
|
